Conclusions: Together, our study not only revealed that CXCL10 is associated with HRD but also introduced a potential new perspective for identifying prognostic biomarkers of immunotherapy. This evidence concerns the gene CXCL10 and hypoparathyroidism-retardation-dysmorphism syndrome.